• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[The effect of weight reduction on compensation in diabetic obese patients with non-insulin dependent diabetes mellitus].

作者信息

Szabó M

机构信息

Interní klinika IPVZ, spolupracující centrum SZO pro studium diabetu se sídlem ve Zlínĕ.

出版信息

Vnitr Lek. 1998 Mar;44(3):145-50.

PMID:9820092
Abstract

Non-insulin-dependent diabetes mellitus is associated with obesity in 80 to 90%. The presence of obesity enhances insulin resistance, which increases the demands on insulin secretion and causes deterioration of glucose tolerance. Hyperinsulinism has some metabolic sequelae which increase the risk of the development and progression of atherosclerosis. Reduction of body weight is a basic therapeutic provision in obese diabetics. It results not only in better compensation of diabetes but also other metabolic parameters and blood pressure as it leads to a higher tissue sensitivity for insulin. This can delay the development of long-term complications of diabetes mellitus.

摘要

相似文献

1
[The effect of weight reduction on compensation in diabetic obese patients with non-insulin dependent diabetes mellitus].
Vnitr Lek. 1998 Mar;44(3):145-50.
2
[The effect of body weight on insulin activity].[体重对胰岛素活性的影响]
Vnitr Lek. 1999 Sep;45(9):540-4.
3
Beta-cell function and mass in type 2 diabetes.2型糖尿病中的β细胞功能与数量
Dan Med Bull. 2009 Aug;56(3):153-64.
4
Lack of association between the Pro12Ala polymorphism in PPAR-gamma2 gene and body weight changes, insulin resistance and chronic diabetic complications in obese patients with type 2 diabetes.PPAR-γ2基因Pro12Ala多态性与2型糖尿病肥胖患者体重变化、胰岛素抵抗及慢性糖尿病并发症之间无关联。
Arch Med Res. 2006 Aug;37(6):736-43. doi: 10.1016/j.arcmed.2006.01.009.
5
Management of obesity in NIDDM (non-insulin-dependent diabetes mellitus).非胰岛素依赖型糖尿病(NIDDM)中肥胖的管理。
Singapore Med J. 1998 Aug;39(8):380-4.
6
Effect of insulin and energy restriction on the thermic effect of protein in type 2 diabetes mellitus.胰岛素与能量限制对2型糖尿病患者蛋白质热效应的影响
Obes Res. 2001 Apr;9(4):241-50. doi: 10.1038/oby.2001.28.
7
New antiobesity agents in type 2 diabetes: overview of clinical trials with sibutramine and orlistat.2型糖尿病的新型抗肥胖药物:西布曲明和奥利司他的临床试验综述
Diabetes Metab. 2002 Dec;28(6 Pt 1):437-45.
8
Glimepiride pharmacokinetics in obese versus non-obese diabetic patients.格列美脲在肥胖与非肥胖糖尿病患者中的药代动力学。
Ann Pharmacother. 2004 Jan;38(1):30-5. doi: 10.1345/aph.1C397.
9
Promising new approaches.有前景的新方法。
Diabetes Obes Metab. 1999 May;1 Suppl 1:S41-8.
10
Leptin concentration in non-obese and obese children with type 1 diabetes mellitus.1型糖尿病非肥胖和肥胖儿童的瘦素浓度
Biomed Pharmacother. 2000 Mar;54(2):69-73. doi: 10.1016/S0753-3322(00)88854-X.